Solaer Renewable Energies Ltd
TASE:SOLR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Solaer Renewable Energies Ltd
TASE:SOLR
|
IL |
|
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
|
CN |
|
Federated Hermes Inc
NYSE:FHI
|
US |
|
N
|
Nature Wood Group Ltd
NASDAQ:NWGL
|
MO |
|
G
|
Garden Stage Ltd
NASDAQ:GSIW
|
HK |
|
B
|
Bingo Software Co Ltd
SSE:688227
|
CN |
|
O
|
Odonate Therapeutics Inc
OTC:ODTC
|
US |
Balance Sheet
Balance Sheet Decomposition
Solaer Renewable Energies Ltd
Solaer Renewable Energies Ltd
Balance Sheet
Solaer Renewable Energies Ltd
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2
|
2
|
27
|
49
|
70
|
153
|
62
|
|
| Cash |
2
|
2
|
27
|
49
|
70
|
153
|
62
|
|
| Short-Term Investments |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
17
|
31
|
33
|
22
|
59
|
|
| Accounts Receivables |
0
|
1
|
6
|
6
|
14
|
8
|
24
|
|
| Other Receivables |
1
|
1
|
10
|
25
|
19
|
14
|
36
|
|
| Other Current Assets |
2
|
5
|
21
|
16
|
35
|
104
|
265
|
|
| Total Current Assets |
5
|
9
|
65
|
98
|
137
|
279
|
386
|
|
| PP&E Net |
22
|
47
|
371
|
603
|
818
|
974
|
1 006
|
|
| PP&E Gross |
22
|
47
|
371
|
603
|
818
|
974
|
1 006
|
|
| Accumulated Depreciation |
2
|
3
|
6
|
9
|
26
|
48
|
49
|
|
| Goodwill |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
6
|
18
|
18
|
66
|
61
|
74
|
73
|
|
| Long-Term Investments |
6
|
3
|
0
|
1
|
0
|
6
|
21
|
|
| Other Long-Term Assets |
1
|
3
|
6
|
5
|
17
|
22
|
38
|
|
| Other Assets |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
40
N/A
|
80
+99%
|
462
+478%
|
774
+67%
|
1 034
+34%
|
1 356
+31%
|
1 525
+12%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
35
|
12
|
5
|
9
|
48
|
|
| Accrued Liabilities |
1
|
2
|
2
|
7
|
6
|
8
|
36
|
|
| Short-Term Debt |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
7
|
130
|
57
|
74
|
234
|
|
| Other Current Liabilities |
2
|
2
|
10
|
10
|
8
|
6
|
159
|
|
| Total Current Liabilities |
6
|
7
|
56
|
160
|
75
|
97
|
478
|
|
| Long-Term Debt |
23
|
74
|
307
|
378
|
730
|
861
|
758
|
|
| Deferred Income Tax |
1
|
3
|
42
|
33
|
44
|
73
|
46
|
|
| Minority Interest |
0
|
1
|
45
|
35
|
26
|
35
|
20
|
|
| Other Liabilities |
1
|
1
|
1
|
2
|
1
|
1
|
0
|
|
| Total Liabilities |
30
N/A
|
85
+182%
|
450
+431%
|
609
+35%
|
875
+44%
|
1 066
+22%
|
1 303
+22%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
7
|
7
|
151
|
127
|
242
|
192
|
|
| Unrealized Security Profit/Loss |
0
|
3
|
6
|
22
|
36
|
49
|
30
|
|
| Other Equity |
0
|
1
|
1
|
7
|
4
|
1
|
0
|
|
| Total Equity |
10
N/A
|
5
N/A
|
12
N/A
|
165
+1 281%
|
159
-4%
|
289
+82%
|
222
-23%
|
|
| Total Liabilities & Equity |
40
N/A
|
80
+99%
|
462
+478%
|
774
+67%
|
1 034
+34%
|
1 356
+31%
|
1 525
+12%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
14
|
14
|
16
|
16
|
|